Antibody drug conjugates coming to primetime and new agents for breast cancer

Cancer advocacy and fundraising in Nigeria

ASCO 2024: Advances in NSCLC

Complementing clinical trials: Investigating the value of real world evidence with insights from TE NDMM

Treatment of multiple myeloma in Turkey

Grand Rounds: Improving quality of patient-centred care

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Global trends and inequalities in breast cancer survival and care

Updates on lung cancer from WCLC and ESMO 2023

Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma

The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa

ASCO's strategic plan for cancer care in LMICs